(Q79799774)

English

Early clearance of peripheral blasts measured by flow cytometry during the first week of AML induction therapy as a new independent prognostic factor: a GOELAMS study

scientific article published on 06 November 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18987664%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Early clearance of peripheral blasts measured by flow cytometry during the first week of AML induction therapy as a new independent prognostic factor: a GOELAMS study (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18987664%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

1 reference

based on heuristic

inferred from title

René-Olivier Casasnovas

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18987664%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

author name string

F Lacombe

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18987664%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

C Arnoulet

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18987664%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

M Maynadié

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18987664%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

E Lippert

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18987664%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

I Luquet

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18987664%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

A Pigneux

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18987664%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

N Vey

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18987664%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

F Witz

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18987664%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

M C Béné

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18987664%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

publication date

6 November 2008

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18987664%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18987664%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

23

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18987664%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18987664%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

350-357

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18987664%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

describes a project that uses

1 reference

based on heuristic

inferred from title

https://scigraph.springernature.com/pub.10.1038/leu.2008.296

0 references

Acute myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.296

7 January 2021

based on heuristic

inferred from DOI database lookup

New molecular therapy targets in acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.296

7 January 2021

based on heuristic

inferred from DOI database lookup

Acute myeloid leukaemia M0: haematological, immunophenotypic and cytogenetic characteristics and their prognostic significance: an analysis in 241 patients

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.296

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunophenotypic patterns and cytogenetic anomalies in acute non-lymphoblastic leukemia subtypes: a prospective study of 432 patients

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.296

7 January 2021

based on heuristic

inferred from DOI database lookup

The molecular pathogenesis of acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.296

7 January 2021

based on heuristic

inferred from DOI database lookup

The World Health Organization (WHO) classification of the myeloid neoplasms

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.296

7 January 2021

based on heuristic

inferred from DOI database lookup

A simple, robust, validated and highly predictive index for the determination of risk-directed therapy in acute myeloid leukaemia derived from the MRC AML 10 trial

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.296

7 January 2021

based on heuristic

inferred from DOI database lookup

Early blast clearance by remission induction therapy is a major independent prognostic factor for both achievement of complete remission and long-term outcome in acute myeloid leukemia: data from the German AML Cooperative Group (AMLCG) 1992 Trial

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.296

7 January 2021

based on heuristic

inferred from DOI database lookup

Predicting remission outcome in acute non-lymphocytic leukemia: General principles and their application to residual marrow leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.296

7 January 2021

based on heuristic

inferred from DOI database lookup

Monitoring of minimal residual disease in acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.296

7 January 2021

based on heuristic

inferred from DOI database lookup

Monitoring of minimal residual disease in adult acute myeloid leukemia using peripheral blood as an alternative source to bone marrow

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.296

7 January 2021

based on heuristic

inferred from DOI database lookup

Early immunophenotypical evaluation of minimal residual disease in acute myeloid leukemia identifies different patient risk groups and may contribute to postinduction treatment stratification

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.296

7 January 2021

based on heuristic

inferred from DOI database lookup

Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.296

7 January 2021

based on heuristic

inferred from DOI database lookup

Flow cytometric method for enumeration and classification of reactive immature granulocyte populations

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.296

7 January 2021

based on heuristic

inferred from DOI database lookup

Proposed reference method for peripheral-blood monocyte counting using fluorescence-labelled monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.296

7 January 2021

based on heuristic

inferred from DOI database lookup

Flow cytometry CD45 gating for immunophenotyping of acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.296

7 January 2021

based on heuristic

inferred from DOI database lookup

Chromosome aberrations, gene mutations and expression changes, and prognosis in adult acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.296

7 January 2021

based on heuristic

inferred from DOI database lookup

Early peripheral blood blast clearance during induction chemotherapy for acute myeloid leukemia predicts superior relapse-free survival

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.296

7 January 2021

based on heuristic

inferred from DOI database lookup

The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.296

7 January 2021

based on heuristic

inferred from DOI database lookup

Abnormal Cytogenetics at Date of Morphologic Complete Remission Predicts Short Overall and Disease-Free Survival, and Higher Relapse Rate in Adult Acute Myeloid Leukemia: Results From Cancer and Leukemia Group B Study 8461

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.296

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q79799774&oldid=2077164423"